Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KAPA Kairos Pharma, Ltd.

休市中 08-21 16:00:00 EDT

0.2900

-0.0051

-1.73%

盘后0.2653

-0.0247-8.52%

19:55 EDT

最高0.3014	最低0.2890	成交量29.76万
今开0.2900	昨收0.2951	日振幅4.20%
总市值687.23万	流通市值342.61万	总股本2,370万
成交额8.70万	换手率2.52%	流通股本1,181万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KAPA","market":"US","secType":"STK","nameCN":"Kairos Pharma, Ltd.","latestPrice":0.29,"timestamp":1787342400000,"preClose":0.2951,"halted":0,"volume":297565,"hourTrading":{"tag":"盘后","latestPrice":0.2653,"preClose":0.29,"latestTime":"19:55 EDT","volume":187006,"amount":51420.65805,"timestamp":1787356523190,"change":-0.0247,"changeRate":-0.085172,"amplitude":0.106552},"delay":0,"changeRate":-0.017282277194171445,"floatShares":11814300,"shares":23697683,"eps":-0.278135,"marketStatus":"休市中","change":-0.0051,"latestTime":"08-21 16:00:00 EDT","open":0.29,"high":0.3014,"low":0.289,"amount":86964.0020878,"amplitude":0.04202,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.278135,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1717992000000,"exchange":"AMEX","adjPreClose":0.2951,"preHourTrading":{"tag":"盘前","latestPrice":0.295,"preClose":0.2951,"latestTime":"09:23 EDT","volume":5590,"amount":1644.9098783000002,"timestamp":1787318623661,"change":-0.0001,"changeRate":-0.000339,"amplitude":0.154524},"postHourTrading":{"tag":"盘后","latestPrice":0.2653,"preClose":0.29,"latestTime":"19:55 EDT","volume":187006,"amount":51420.65805,"timestamp":1787356523190,"change":-0.0247,"changeRate":-0.085172,"amplitude":0.106552},"volumeRatio":1.0198888000261668},"requestUrl":"/m/hq/s/KAPA","defaultTab":"news","newsList":[{"id":"1111347849","title":"Kairos Pharma与拜耳达成战略合作，旨在提升Xofigo在转移性前列腺癌治疗中的活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1111347849","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111347849?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:36","pubTimestamp":1784723774,"startTime":"0","endTime":"0","summary":"Kairos Pharma宣布与拜耳建立战略合作关系，双方将携手增强Xofigo在转移性前列腺癌领域的治疗活性。此次合作旨在通过资源整合与研发协同，探索并提升现有疗法的临床潜力，为患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197314974","title":"Kairos Pharma公布Env-105在EGFR突变肺癌患者中一期试验突破性中期安全性数据——瞄准百亿美元耐药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1197314974","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197314974?lang=zh_cn&edition=full","pubTime":"2026-07-15 20:31","pubTimestamp":1784118683,"startTime":"0","endTime":"0","summary":"Kairos Pharma公布了其药物Env-105在针对EGFR突变肺癌患者的一期临床试验中取得的突破性中期安全性数据。该研究旨在攻克一个价值高达百亿美元的肿瘤耐药市场，为应对棘手的药物耐药性难题提供了新的潜在解决方案。此次积极的安全性数据为后续的疗效评估和开发进程奠定了重要基础，有望为现有治疗选择有限的患者群体带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186264148","title":"Kairos Pharma, Ltd. 确定年度股东大会日期并更新年报提交情况","url":"https://stock-news.laohu8.com/highlight/detail?id=1186264148","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186264148?lang=zh_cn&edition=full","pubTime":"2026-05-09 04:31","pubTimestamp":1778272283,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. 已确定其年度股东大会的召开日期，并就其年度申报文件的提交情况提供了最新信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180765105","title":"Kairos Pharma签署具有约束力的战略资产收购协议，获得Orbimed及Torrey Pines投资支持的Celyn Therapeutics旗下Cl-273全球独家授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1180765105","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180765105?lang=zh_cn&edition=full","pubTime":"2026-03-02 19:30","pubTimestamp":1772451016,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. (简称：Kairos Pharma) 正式宣布，已签署一项具有约束力的战略资产收购协议。根据协议，Kairos Pharma将获得来自Orbimed及Torrey Pines投资支持的Celyn Therapeutics所持有的Cl-273项目的全球独家权利。\n此次收购标志着Kairos Pharma在拓展其产品管线方面迈出关键一步，进一步巩固了公司在创新疗法领域的战略布局。Cl-273作为一项具有潜力的候选药物，其全球独家权利的获取将为公司未来业务增长注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614020606","title":"Kairos Pharma, Ltd.股价上涨13.85% 市值涨206.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614020606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614020606?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:31","pubTimestamp":1772116291,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时31分，Kairos Pharma, Ltd.股票出现波动，股价快速拉升13.85%。Kairos Pharma, Ltd.股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，Curanex Pharmaceuticals Inc、Liminatus Pharma Inc C/Wts 30/04/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Curanex Pharmaceuticals Inc、Kairos Pharma, Ltd.、Edesa Biotech, Inc.较为活跃，换手率分别为152.34%、82.55%、22.86%，振幅较大的相关个股有Edesa Biotech, Inc.、Curanex Pharmaceuticals Inc、Moolec Science Sa C/Wts 30/01/2028，振幅分别为10.29%、9.35%、9.27%。Kairos Pharma, Ltd.公司简介：Kairos Pharma Ltd 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223131a4cbf589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223131a4cbf589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614008551","title":"Uniqure N.V.股价重挫16.96% 市值涨5422.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008551","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614008551?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:30","pubTimestamp":1772116209,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时30分，Uniqure N.V.股票出现异动，股价大幅跳水16.96%。截至发稿，该股报20.65美元/股，成交量202.299万股，换手率3.25%，振幅8.78%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223010a722dad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223010a722dad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","LU0320765992.SGD","QURE","LU0109394709.USD","LU0889565916.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157906189","title":"Kairos制药有限公司签署条款书，拟战略性收购Celyn Therapeutics两项临床肿瘤资产","url":"https://stock-news.laohu8.com/highlight/detail?id=1157906189","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157906189?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:02","pubTimestamp":1772107360,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. 已与Celyn Therapeutics达成协议，签署了一份关于战略性资产收购的条款书。根据该条款书，Kairos将收购Celyn Therapeutics旗下的两项临床阶段肿瘤治疗资产。这一举措标志着Kairos在拓展其肿瘤治疗产品线方面迈出了重要一步，有望进一步增强公司在临床肿瘤领域的研发实力和市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503655592","title":"Cosciens Biopharma Inc.盘中异动 快速下跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503655592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503655592?lang=zh_cn&edition=full","pubTime":"2025-01-14 04:57","pubTimestamp":1736801859,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日04时57分，Cosciens Biopharma Inc.股票出现波动，股价快速跳水6.47%。截至发稿，该股报3.18美元/股，成交量3143股，换手率0.10%，振幅4.71%。Cosciens Biopharma Inc.股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为16045.66%、8271.05%、876.89%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045739a220990e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045739a220990e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAIR","KAPA","CSCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503721553","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.11%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503721553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503721553?lang=zh_cn&edition=full","pubTime":"2025-01-14 04:56","pubTimestamp":1736801791,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日04时56分，Nautilus Biotechnology, Inc.股票出现异动，股价快速上涨5.11%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为16033.67%、8260.93%、876.67%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045631aba98ab9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114045631aba98ab9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT","KAIR","BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503558257","title":"Pmgc Holdings Inc.盘中异动 下午盘快速上涨5.21%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503558257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503558257?lang=zh_cn&edition=full","pubTime":"2025-01-14 04:29","pubTimestamp":1736800161,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日04时29分，Pmgc Holdings Inc.股票出现异动，股价快速上涨5.21%。截至发稿，该股报2.17美元/股，成交量15.3633万股，换手率5.00%，振幅9.42%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为15690.78%、8073.42%、858.60%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140429219602870a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140429219602870a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","KAPA","BK4139","KAIR","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503425532","title":"Sab Biotherapeutics, Inc.盘中异动 下午盘股价大跌5.99%报3.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503425532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503425532?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:24","pubTimestamp":1736796259,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日03时24分，Sab Biotherapeutics, Inc.股票出现异动，股价快速跳水5.99%。Sab Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Sab Biotherapeutics, Inc.公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114032420aba97649&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114032420aba97649&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","BK4139","SABS","KAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503532658","title":"Chimerix, Inc.盘中异动 快速拉升5.23%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503532658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503532658?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:19","pubTimestamp":1736795949,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日03时19分，Chimerix, Inc.股票出现异动，股价大幅上涨5.23%。Chimerix, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为14898.03%、7709.62%、736.66%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。Chimerix, Inc.公司简介：Chimerix Inc.是一家总部位于美国的生物制药公司，从事药物的研究，开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114031909986501f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114031909986501f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAIR","CMRX","BK4583","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503532681","title":"Benitec Biopharma Inc.盘中异动 急速跳水6.00%报10.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503532681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503532681?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:18","pubTimestamp":1736795885,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日03时18分，Benitec Biopharma Inc.股票出现波动，股价快速下挫6.00%。截至发稿，该股报10.34美元/股，成交量2.1242万股，换手率0.09%，振幅3.05%。Benitec Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Benitec Biopharma Inc.公司简介：Benitec Biopharma Inc 是一家临床阶段的生物技术公司，专注于新型基因药物的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114031805a22082f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114031805a22082f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","BK4139","KAPA","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503349985","title":"珐博进盘中异动 下午盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503349985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503349985?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:03","pubTimestamp":1736795003,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日03时03分，珐博进股票出现波动，股价急速下跌5.21%。截至发稿，该股报0.584美元/股，成交量89.9453万股，换手率0.89%，振幅10.18%。珐博进股票所在的生物技术行业中，整体涨幅为0.69%。迄今为止，珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴，以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011403032396027c61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011403032396027c61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4505","KAPA","KAIR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503753715","title":"Surrozen Inc C/Wts 01/08/2031 (To Pur Com)盘中异动 股价大跌10.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503753715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503753715?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:02","pubTimestamp":1736794921,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日03时02分，Surrozen Inc C/Wts 01/08/2031 股票出现异动，股价快速下挫10.34%。截至发稿，该股报0.052美元/股，成交量5545股，换手率0.02%，振幅0.00%。Surrozen Inc C/Wts 01/08/2031 股票所在的生物技术行业中，整体涨幅为0.68%。Surrozen Inc C/Wts 01/08/2031 公司简介：Surrozen Inc 是一家临床阶段的生物技术公司，致力于发现和开发候选药物，以选择性地调节 Wnt 通路——一种多种器官和组织中组织修复的关键介质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114030201a2207f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114030201a2207f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SRZNW","BK4139","KAPA","KAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503531433","title":"Rocket Pharmaceuticals Inc C/Wts 02/09/2026 (To Pur Com)股价重挫19.19% 市值跌585.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503531433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503531433?lang=zh_cn&edition=full","pubTime":"2025-01-14 02:45","pubTimestamp":1736793901,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日02时45分，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 股票出现波动，股价急速下跌19.19%。Rocket Pharmaceuticals Inc C/Wts 02/09/2026 股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为14448.23%、7546.35%、719.06%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。Rocket Pharmaceuticals Inc C/Wts 02/09/2026 公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114024501a2207c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114024501a2207c20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAPA","KAIR","RCKTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503441531","title":"Zymeworks Inc.盘中异动 快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503441531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503441531?lang=zh_cn&edition=full","pubTime":"2025-01-14 02:35","pubTimestamp":1736793327,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日02时35分，Zymeworks Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报13.89美元/股，成交量41.7245万股，换手率0.61%，振幅8.09%。Zymeworks Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Zymeworks Inc.公司简介：Zymeworks Inc 是一家临床阶段的生物制药公司，致力于下一代多功能生物治疗药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114023527aba96b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114023527aba96b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZYME","KAIR","KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503539179","title":"Pharming Group Nv盘中异动 股价大跌5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503539179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503539179?lang=zh_cn&edition=full","pubTime":"2025-01-14 02:26","pubTimestamp":1736792801,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日02时26分，Pharming Group Nv股票出现异动，股价快速下挫5.87%。截至发稿，该股报9.14美元/股，成交量3714股，换手率0.01%，振幅8.34%。Pharming Group Nv股票所在的生物技术行业中，整体涨幅为0.49%。Pharming Group Nv公司简介：Pharming Group 是一家全球生物制药公司，致力于改善患有罕见、严重和危及生命疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011402264196027798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011402264196027798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","BK4139","PHAR","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503539517","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503539517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503539517?lang=zh_cn&edition=full","pubTime":"2025-01-14 02:05","pubTimestamp":1736791535,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日02时05分，Clearside Biomedical, Inc.股票出现异动，股价快速下挫5.10%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为13061.49%、7412.21%、682.47%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、221.73%、201.86%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114020535a22073b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114020535a22073b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","KAIR","BK4139","KAPA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503536117","title":"Orchestra Biomed Holdings, Inc.盘中异动 股价大跌5.39%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503536117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503536117?lang=zh_cn&edition=full","pubTime":"2025-01-14 01:54","pubTimestamp":1736790867,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日01时54分，Orchestra Biomed Holdings, Inc.股票出现异动，股价快速下跌5.39%。Orchestra Biomed Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为12947.95%、7370.97%、669.76%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、221.73%、201.86%。Orchestra Biomed Holdings, Inc.公司简介：Orchestra BioMed Holdings Inc 是一家生物医学创新公司，通过风险回报共享合作伙伴关系加速为患者提供高影响力技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140154279864f66b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140154279864f66b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4082","KAIR","KAPA","OBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kairospharma.com","stockEarnings":[{"period":"1week","weight":-0.1496},{"period":"1month","weight":-0.0726},{"period":"3month","weight":-0.4679},{"period":"6month","weight":-0.4777},{"period":"1year","weight":-0.7521},{"period":"ytd","weight":-0.5915}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kairos Pharma, Ltd.于2013年6月17日根据加利福尼亚州法律注册成立，名称为NanoGB13, Inc.，随后于2023年5月10日转换为特拉华州公司，名称为Kairos Pharma, Ltd.。该公司是一家临床阶段的生物制药公司，致力于为癌症患者提供治疗，旨在克服免疫抑制和耐药性方面的关键障碍。这些疗法包括用于治疗前列腺癌、肺癌、乳腺癌和胶质母细胞瘤的抗体和小分子。","exchange":"AMEX","name":"Kairos Pharma, Ltd.","nameEN":"Kairos Pharma, Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kairos Pharma, Ltd.(KAPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kairos Pharma, Ltd.,KAPA,Kairos Pharma, Ltd.股票,Kairos Pharma, Ltd.股票老虎,Kairos Pharma, Ltd.股票老虎国际,Kairos Pharma, Ltd.行情,Kairos Pharma, Ltd.股票行情,Kairos Pharma, Ltd.股价,Kairos Pharma, Ltd.股市,Kairos Pharma, Ltd.股票价格,Kairos Pharma, Ltd.股票交易,Kairos Pharma, Ltd.股票购买,Kairos Pharma, Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kairos Pharma, Ltd.(KAPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kairos Pharma, Ltd.(KAPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}